Lv7
3470 积分 2020-08-22 加入
Lipoprotein(a) Reduction in Persons with Cardiovascular Disease
11分钟前
待确认
2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias
19小时前
待确认
Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome
22小时前
待确认
Abstract 17013: CTX320: An Investigational in vivo CRISPR-Based Therapy Efficiently and Durably Reduces Lipoprotein (a) Levels in Non-Human Primates After a Single Dose
10天前
已关闭
Baseline and on-statin treatment lipoprotein(a) levels for prediction of cardiovascular events: individual patient-data meta-analysis of statin outcome trials
11天前
已完结
Statin therapy increases lipoprotein(a) levels
11天前
已完结
Lipoprotein(a)-lowering therapies: a promising future
11天前
已完结
The Additive Prognostic Value of Lipoprotein(a) for All-cause and Cardiovascular Mortality Across the Traditional Cardiovascular Risk Continuum: Analysis from NHANES III (1988–1994) with Follow-Up to 2019
13天前
已完结
Primary Aldosteronism: An Endocrine Society Clinical Practice Guideline
17天前
已完结
Transcatheter Aortic Valve Replacement in Patients With Systolic Heart Failure and Moderate Aortic Stenosis: TAVR UNLOAD
25天前
已完结
皖公网安备34019202002308
